Skip to main content
Clinical Trials/NCT05767203
NCT05767203
Recruiting
Not Applicable

Search for Genetic Markers and Biomarkers to Follow Patients With Intellectual Disabilities of Genetic Origin and to Understand Its Origin and Associated Comorbidities

Institut Jerome Lejeune1 site in 1 country2,000 target enrollmentSeptember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Down Syndrome
Sponsor
Institut Jerome Lejeune
Enrollment
2000
Locations
1
Primary Endpoint
Identification of biomarkers in blood
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Analyze genetic and biological markers in patients with Intellectual Deficiencies (ID) of genetic origin in order to better understand the mechanisms of modified genes, cellular mechanisms, pathways involved in different disorders , complications and pathologies associated with ID of genetic origin.

Detailed Description

Blood and skin samples will be taken from patients coming at the outpatients clinic of the Institut Jérôme Lejeune and who consent to participate to the study. Search and identification of markers will be then done from the collected samples.

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
December 31, 2032
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient diagnosed with an intellectual disability of genetic origin
  • Patient of all ages coming for consultation at the Institut Jérôme Lejeune
  • Patient whose parents or legal representative have received and understood the information document and signed the informed consent for a sample for the research project.
  • Patient affiliated to a social security scheme

Exclusion Criteria

  • Parents unable to find out about the constraints related to the study
  • Refusal of informed patient participation
  • Pregnant, parturient and nursing mothers
  • Persons deprived of their liberty by judicial or administrative decision

Outcomes

Primary Outcomes

Identification of biomarkers in blood

Time Frame: 10 years

Analysis of biomarkers from blood samples taken during the visit

Identification of biomarkers from skin samples

Time Frame: 10 years

Analysis of biomarkers from skin samples taken during the visit

Study Sites (1)

Loading locations...

Similar Trials